Early clinical investigation of Viozan (sibenadet HCl), a novel D2 dopamine receptor, β2-adrenoceptor agonist for the treatment of chronic obstructive pulmonary disease symptoms: Developing new therapies for chronic obstructive pulmonary disease: lessons learned from the novel D2/β2 agonist, ViozanTM

Bibliographische Detailangaben

Veröffentlicht in:	Respiratory medicine 2003, Vol.97, p.S9-S21
Hauptverfasser:	IND, P. W, LAITINEN, L, LAURSEN, L, WENZEL, S, WOUTERS, E, DEAMER, L, NYSTROM, P
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Chronic obstructive pulmonary disease, asthma Medical sciences Pneumology Respiratory system : syndromes and miscellaneous diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!